Copyright
©The Author(s) 2018.
World J Gastroenterol. Feb 7, 2018; 24(5): 631-640
Published online Feb 7, 2018. doi: 10.3748/wjg.v24.i5.631
Published online Feb 7, 2018. doi: 10.3748/wjg.v24.i5.631
Figure 1 Kaplan-Meier survival analysis for overall survival in patients with stage II/III colorectal cancer according to TP53 mutation status (A); PIK3CA mutation status (B); and PIK3CA and TP53 mutation status (C).
- Citation: Li AJ, Li HG, Tang EJ, Wu W, Chen Y, Jiang HH, Lin MB, Yin L. PIK3CA and TP53 mutations predict overall survival of stage II/III colorectal cancer patients. World J Gastroenterol 2018; 24(5): 631-640
- URL: https://www.wjgnet.com/1007-9327/full/v24/i5/631.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i5.631